NewsXcell and Labcorp team up to develop cell and...

Xcell and Labcorp team up to develop cell and gene therapies


It has been announced that Labcorp will collaborate with the biotechnology company xCell Biosciences to advance the development of new cell and gene therapies (CGTs).

As a result of the alliance, the companies will work together on a variety of projects to improve the safety and efficacy of CGTs.

It supports Labcorp’s commitment to expanding its worldwide, complete CGT expertise while helping pharmaceutical and biotechnology companies speed up the development of treatments.

CGTs alter the genes of a person in order to treat diseases, either by disabling or substituting a disease-causing gene, or by introducing a new or modified cell or gene into the body.

Many diseases, from Parkinson’s to solid tumours to rare diseases to blood-based malignancies, are being studied in the hope that one of these treatments will be effective.

Xcellbio’s AVATAR incubator system will be used by the partnership’s projects to develop research-grade CAR-T cell material that can be used to kill cancer cells.

This initiative will help demonstrate the importance of knowing the parameters of the tumour microenvironment in order to create CAR-T cells that perform at a higher level.

In addition, the technology will be used to adapt cancer cells to more physiological conditions and extend 3D modelling for in vitro CAR-T testing.

Following a strategic investment in Xcellbio made by Labcorp in November of last year, a new partnership has been formed.

According to Dr. Maryland Franklin, the head of the Labcorp cell and gene therapy enterprise and vice president, “Labcorp is firmly committed to assisting our clients in providing new treatment options to patients in need while also revolutionizing the future of medicine through the use of cell and gene therapies.”

“The combination of the scale and breadth of our enterprise-wide CGT solutions with Xcellbio’s powerful technology provides us with an opportunity to enhance and accelerate the CGT development experience.”

Cytiva provides support for cell and gene therapy coverage in the field of pharmaceutical technology.

Editorial content is created in an independent manner and adheres to the highest standards of journalistic ethics and integrity. The creation of editorial content is not influenced by topic sponsors in any way.

Also read: Minicorns and Leaders of Wearable Technology Chosen by Somatix

Technology has been James's passion for over a decade. After graduating from the University of Chester with a Bachelor of Arts degree in Journalism in 2006, started writing full-time shortly after. Over the years, he has worked on everything from Windows XP to Red Star OS, but more recently has settled into the Apple ecosystem. A regular contributor at, James writes about iOS, macOS, and Apple hardware.


Please enter your comment!
Please enter your name here

Latest news

Kyle Forgeard’s Net Worth

Most people know Kyle as one of the brains behind the YouTube channel Neck, which he co-founded. Have you...

Billy Evans Net Worth, Biography. Age, Career, and Family

Billy Evans is a prominent American businessman having a net worth of around $10 million. You can find everything...

Patriot One Technologies is selected by Central Bank Center for security technology

The Central Bank Center in Lexington, Kentucky, has chosen Patriot One Technologies' SmartGatewayTM solution to safeguard the entrances to...

Mixed reality headset was reportedly shown off by Apple to the company’s board of directors

According to Bloomberg, Apple's board of directors had a hands-on demo of the company's upcoming mixed-reality headset last week....

5WPR announces creation of a dedicated PR division for travel technology

NEW YORK, May 19th, 2022/PRNewswire/— 5WPR, one of the largest independently-owned PR firms in the United States, has announced...

Thagora Acquires Leading Seating Material Company by LEAR

May 19, 2022/PRNewswire/Southfield, Mich.— As a global leader in automotive seating and electronic systems, Lear Corporation (NYSE: LEA) announced...

Must read

You might also likeRELATED
Recommended to you